Access cutting-edge pregnancy complications treatment through this clinical trial at a research site in San Francisco. Study-provided care at no cost to qualified participants.
Access pregnancy complications specialists in San Francisco at no cost
This study follows strict safety protocols and ethical guidelines
All study-related pregnancy complications treatment provided free
The overall goal of this large, pragmatic, comparative effectiveness trial is to test the hypothesis that among at-risk individuals, 162 mg/day aspirin is superior to 81 mg/day in preventing Hypertensive disorders of pregnancy (HDP), and that there are multiple factors associated with adherence with aspirin therapy that will be important to identify to enable optimal implementation of study findings and population-level benefits.
Sponsor: Ohio State University
Check if you qualify for this pregnancy complications clinical trial in San Francisco, CA
If you're searching for pregnancy complications treatment options in San Francisco, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our San Francisco research site is actively enrolling participants for this clinical trial. You'll receive care from experienced pregnancy complications specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.